Xtrenbo Injection
Product Images NDC 0143-9166

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Xtrenbo (NDC 0143-9166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xtrenbo Figure 1 (Xtrenbo Denosumab Qbde Injection 1)

A line graph showing corrected calcium levels over various study days for Denosumab 120 mg (N=23). The x-axis represents study days including baseline (BL) and multiple days up to day 57. The y-axes display calcium concentrations in both mmol/L (left) and mg/dL (right). Error bars indicate variability at each time point.*

FDA Label Image

Xtrenbo_label (Xtrenbo Denosumab Qbde Injection 2)

XTRENBO 120 mg/1.7 mL (70 mg/mL) injection label for subcutaneous use. The label indicates it is a single-dose vial with instructions to discard any unused portion. It includes the NDC number 0143-9166-01, the labeler Hikma Pharmaceuticals USA Inc., and a US license number 2356. A barcode and lot/expiration information area are also visible.*

FDA Label Image

Carton (Xtrenbo Denosumab Qbde Injection 3)

Label for XTRENBO (denosumab-qbde) Injection 120 mg/1.7 mL (70 mg/mL) by Hikma Pharmaceuticals USA Inc. The label states it is a sterile, preservative-free solution for subcutaneous use, in single-dose vials. It includes storage instructions, manufacturer details, and NDC 0143-9166-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.